fda glp-1 news november 2025 Pharmacovigilance Assessment of Compounded Receptor Agonists: Insights From the Adverse Event Reporting System fda glp-1 news november 2025

In an historic first, CRISPR corrected a single error in the infants DNA last year, proving that personalized gene editing is poss

Adding more protein to the diet in the form of whey protein shakes is always an excellent way to both build muscle and lose weight, so if mixing it with [diet] coke encourages more protein intake, I totally co-sign, Moody said

However, poorer glycaemic control is associated with higher diabetes distress scores and improvement in glycaemic control decreases diabetes distress and improves quality of life [63, 64]

Back Finan, B, Yang, B, Ottaway, N, et al (2015) 'A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents', Nature Medicine , 21, 27-26

Krass M, Volke A, Rnkorg K, Wegener G, Lund S, Abildgaard A, et al

The majority of current GLP-1 users have type 2 diabetes as their primary diagnosis, though a growing proportion are using these medications primarily for chronic weight management